ALPMY

Astellas Pharma · USD

Market closed US (NYSE / Nasdaq) · 09:30–16:00 · Sun 22:01 · approx

Deep AI analysis (big model)

No deep analysis yet. Portfolio holdings are analysed automatically; for any other stock, click “Request deep AI analysis” above.

About Astellas Pharma

Astellas Pharma (ALPMY) is a pharmaceutical company that develops and commercializes prescription drugs for various diseases and conditions, operating primarily in the healthcare sector.

Ticker	ALPMY
Name	Astellas Pharma
Currency	USD

Reputation

🙂

How liked 50/100

From 0 recent analysed stories — 0 good · 0 bad · 0 neutral. Trend: stable.

Reputation builds as news about this company is analysed.

Price history & forecast

30-day forecast — Linear regression, Holt's exponential smoothing, and drift, plus a news-adjusted consensus (sentiment tilt +0.00). Estimates only, not advice.

Candlestick, volume & news sentiment

good bad neutral

Daily open/high/low/close candles with volume bars beneath; hover a candle for its OHLC, change and volume. Dots mark analysed news coloured by sentiment. Pick a range, or click-and-drag across the chart to zoom in.

Forecast accuracy (backtested)

No scored forecasts yet. Every visit records the day's forecast; once those predicted dates pass, this table fills in with how each method actually did (1 snapshot(s) recorded so far, none matured yet).

Technical analysis

BEARISH

32.47

RSI (14)i

14.09

SMA 20i

14.98

SMA 50i

13.49

SMA 200i

0.00%

1di

-1.93%

1wi

-8.44%

1mi

2.09%

30d voli

16.78

52w highi

9.23

52w lowi

-21.16%

from highi

-0.44

MACDi

Uptrend (50d above 200d)MACD bearish crossover

Computed from 252 locally-stored price bars.

AI signals

HOLD 70% · long_term 2026-06-07 23:39

The stock has been in a downtrend with significant losses over the past week, and there are no recent positive news to support an immediate buy. The price is near its lowest point of the window but hasn't broken below it yet, suggesting some potential for recovery. A long-term perspective would be needed to assess this situation further.

qwen2.5:3b